Lisuride treatment of Restless Legs Syndrome: First studies with monotherapy in de novo patients and in combination with levodopa in advanced disease

Journal of Neural Transmission

Volumn 113, Issue 1, 2006, Pages 87-92

  Benes H ^a,f   Deissler, A ^b   Rodenbeck, A ^c   Engfer, A ^d   Kohnen, R ^e  

^a Somni Bene Institute for Medical Research and Sleep Medicine   (Germany)

^b HELIOS KLINIKEN SCHWERIN   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d BAYER PHARMA AG   (Germany)

^e Inst Med Res Mgmt and Biometr   (Germany)

^f Sleep Medicine Schwerin Ltd   (Germany)

Author keywords

CGI; Clinical trial; Dopamine agonist; Levodopa; Lisuride; Periodic leg movement; Polysomnography; Restless legs syndrome; Therapy

Indexed keywords

LEVODOPA; LISURIDE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; HYPOTENSION; MALE; MONOTHERAPY; NAUSEA; PILOT STUDY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; STOMACH PAIN; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEVODOPA; LISURIDE; MALE; MIDDLE AGED; PILOT PROJECTS; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; SINGLE-BLIND METHOD;

EID: 29244465127     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0386-1     Document Type: Article

References (15)

1. R Allen D Picchietti W Hening C Trenkwalder AS Walters J Montplaisir 2003 Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institute of Health. Sleep Med 4 101 119
2. R Allen PM Becker R Bogan M Schmidt CA Kushida JM Fry JS Poceta D Winslow 2004 Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 27 907 914
3. H Beneš B Kurella J Kummer J Kazenwadel R Selzer R Kohnen 1999 Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomised, multi-center, crossover trial. Sleep 22 1073 1081
4. H Beneš CR Heinrich MA Ueberall R Kohnen 2004 Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. Sleep 27 674 682
5. Beneš H (2005) Transdermal lisuride: first efficacy and tolerability study in patients with severe Restless Legs Syndrome. Sleep Med (E-pub ahead of print)
6. Diagnostic Classification Steering Committee, Thorpy MJ, Chairman (1990) ICSD - International Classification of Sleep Disorders: diagnostic and coding manual. American Sleep Disorders Association, Rochester, Minnesota
7. WA Hening RP Allen CJ Earley DL Picchietti MH Silber Restless Legs Syndrome Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine 2004 An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 560 583
8. Horowski R, Obeso JA (1995) Lisuride - a direct dopamine agonist in the treatment of Parkinson's disease. In: Koller WC, Paulson G (eds) Therapy of Parkinson's disease. Marcel Dekker, New York, pp 219-248
9. National Institute of Mental Health (1976) 028 CGI. Clinical Global Impressions. In: Guy W (ed) ECDEU assessment manual for psychopharmacology. National Institute for Mental Health, Rockville, MD, pp 218-222
10. WH Oertel H Beneš S Happe R Kohnen M Leroux K Stiasny-Kolster 2004 Efficacy of cabergoline for the treatment of sensori-motor symptoms and sleep disturbances in restless legs syndrome: a placebo-controlled, 5-week, double-blind, randomized, multicenter, polysomnographic study. Mov Disord 19 Suppl 9 S425 (Abstract 1247)
11. CW Olanow Y Agid Y Mizuno A Albanese U Bonucelli P Damier J De Yebenes O Gershanik M Guttman F Grandas M Hallett O Hornykiewicz P Jenner R Katzenschlager WJ Langston P LeWitt E Melamed MA Mena PP Michel C Mytilineou JA Obeso W Poewe N Quinn R Raisman-Vozari AH Rajput O Rascol C Sampaio F Stocchi 2004 Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord 19 997 1005
12. K Stiasny-Kolster H Beneš I Peglau M Hornyak B Holinka K Wessel W Emser M Leroux R Kohnen WH Oertel 2004 Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology 63 2272 2279
13. K Stiasny-Kolster R Kohnen E Schollmayer JC Moller WH Oertel 2004 Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord 19 1432 1438
14. C Trenkwalder D Garcia-Borreguero P Montagna E Lainey AW de Weerd P Tidswell G Saletu-Zyhlarz W Telstad L Ferini-Strambi Therapy with Ropinirole; Efficacy and Tolerability in RLS 1 Study Group 2004 Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75 92 97
15. Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K (2004) Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord: 1414-1423